AIG
DNA icon

American International Group’s Ginkgo Bioworks DNA Stock Holding History

American International Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-354
Closed -$16.4K – 763
2024
Q1 		$16.4K Buy
354
+4
+1% +$207 ﹤0.01% 2950
2023
Q4 		$23.7K Sell
350
-5
-1% -$306 ﹤0.01% 2948
2023
Q3 		$25.7K Sell
355
-21
-6% -$1.68K ﹤0.01% 2959
2023
Q2 		$28K Buy
376
+136
+57% +$8.05K ﹤0.01% 2989
2023
Q1 		$12.7K Sell
240
-5
-2% -$317 ﹤0.01% 2935
2022
Q4 		$16.6K Buy
245
+8
+3% +$736 ﹤0.01% 2947
2022
Q3 		$30K Buy
237
+1
+0.4% +$119 ﹤0.01% 2931
2022
Q2 		$22K Buy
+236
New +$28.8K ﹤0.01% 3003

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return